CASE STUDY
James was a 20-year-old Black man recently admitted to the emergency department (ED) for sickle cell crisis. He was quiet and made little eye contact and repeatedly asked for pain medications. He had recently moved and had not reestablished care with a sickle cell physician yet. The social worker in the ED conducted a social history and found that James had to drop out of college because of frequent hospitalizations and recently moved back home with his mother. He had been depressed and anxious and missed all his friends. He had not found work, did not have a car, lived in a rural area, and was unaware of potential sources of disability. James received minimal pain control in the hospital for his crisis, and the case manager helped him advocate for adequate pain relief. The case manager also helped James transition into caring for his own health because his mother had previously helped James navigate throughout the hospital. James was discharged 4 days later after the case manager developed a plan of care with the health care team.
The social worker made an appointment with his primary care physician after discharge and referred him to his case manager in the community for followup. The community case manager worked with James and discussed options for returning to school, maintenance of health, applying for disability, and learning about the local transportation options. Overall, James received education, support, and hope for living well with SCD.
Patients with SCD are admitted to the hospital at a much higher rate than persons with other chronic medical conditions ( Jiang, Barrett, & Sheng, 2014 ) . In 2012, people with SCD had the highest numbers of hospital stays, with four or more stays in 12 months consisting of 57% of all hospital stays for Medicaid "superutilizers" ( Jiang et al., 2014 ) . The most common admission diagnosis is vaso-occlusive episodes (VOEs; NHLBI, 2014 ) . In addition to suffering from acute VOEs, many patients with SCD suffer from chronic daily pain, limiting functional status, movement, and activities and decreasing the quality of life. Treatment of VOEs often requires high doses of opioids, leaving many HCPs with the perception that patients with SCD are addicted to pain medications; many HCPs have negative attitudes toward patients suffering from SCD ( Freiermuth et al., 2014 ; Institute of Medicine, 2012 ) . Health care providers also delay pain medication administration and judge patients who are in need of understanding and receiving adequate pain medication administration ( Institute of Medicine, 2012 ) . The case manager can be a strong advocate for the patient and help educate the health care team to minimize negative attitudes and increase the likelihood of delivery of best practices ( Case Management Society of America, 2016 ).
Thus, caring for persons with SCD is complex from both medical and health services use perspectives. There are many barriers to care. These barriers include clinician and patient knowledge defi cits, chronic pain and the perception of addiction, frequent visits, SCD stigma, and implicit bias. Identifi cation and discussion of these barriers provide a framework for the case manager in a variety of health care settings that care for persons with SCD.
BARRIERS Clinician and Patient Knowledge Defi cits
Comprehensive, educated, and coordinated care for the complex and disabling effects of SCD is necessary for successful patient outcomes. Despite the integral role of HCPs and patient self-care, studies demonstrate that lack of provider knowledge and negative provider attitudes are signifi cant barriers to care ( Haywood et al., 2009 ) . Most primary care physicians have limited experience caring for patients with SCD, and few have more than fi ve patients with SCD ( Mainous et al., 2015 ) . Individualized discharge plans with direct patient involvement can reduce barriers faced after discharge and reduce readmission rates ( Brodsky et al., 2017 ; Cakir, Kaltsounis, D'Jernes, Kopf, & Steiner, 2017 Effective management and coordination of advanced therapies such as blood transfusion, hydroxyurea (HYDREA, DROXIA), and prophylactic antibiotics positively impact successful patient outcomes ( Elmariah et al., 2014 ) . However, providers are often uncomfortable managing patients with SCD who need blood transfusions, hydroxyurea, and pain management ( Mainous et al., 2015 ) . Complex illnesses and complications of SCD impede primary HCPs' management of SCD, as they often feel uneasy and incapable of knowing how to begin treatment.
Providers display increased diffi culty managing SCD pain, and most do not agree that the patient's self-report of pain is the most reliable indicator ( Haywood et al., 2009 ) . Nurses also report a lack of knowledge with narcotic analgesia use in pain crises and have limited experience with patients with SCD ( Haywood et al., 2015 ) . Recent studies have demonstrated improved provider attitudes toward patients with SCD after ongoing educational interventions ( Freiermuth, Silva, Cline, & Tanabe, 2016 ; Hanik, Sackett, & Hartman, 2014 ) . Case managers can provide real-time education to nurses and other HCPs that can lead to improved attitude and better pain management for patients with SCD. In 2014, the NHLBI published evidence-based guidelines and recommendations for the treatment of VOEs. See Box 1.
The case manager can alert staff to the guidelines that provide evidence on how to manage pain and other medical complications.
Self-care is an essential part of managing SCD. Patients must maintain medical appointments, keep up to date on immunizations throughout the life span, ensure adequate hydration, and pay special attention to changes in environmental factors. Identifi cation of factors that place patients at risk for illness leads to greater success in SCD outcomes ( Tanabe et al., 2010 ) . Patients who lack the ability to maneuver through the health care system or have limited knowledge of their disease may not receive adequate pain control and suffer poor health care experiences and outcomes. The case manager can play an important role in assessing the patient's knowledge of the disease and self-management strategies. This knowledge may be benefi cial for the patient's interactions with staff and for overall patient medical management. Advocacy is essential to the case manager's role, which includes putting the patient fi rst and knowing the patient's usual state of health and pain medication schedule ( Tahan, 2016 ) . The case manager can help the patient with SCD navigate transitions by promoting self-care, encouraging clear communication, and educating the team about the patient's history.
BOX 1 Summary of VOE Recommendations
Consider causes of pain other than VOEs.
Conduct a thorough assessment of pain, including patient's recent analgesic use (opioid and nonopiod), as well as patient's knowledge of what agents have been successful in the past.
Initiate analgesic therapy within 30 min of triage or 60 min of registration (emergency department management).
Use an individualized prescribing and monitoring protocol or an SCD-specifi c protocol to promote rapid, effective, and safe analgesic management and resolution of VOEs.
Treat with NSAIDs for persons with mild to moderate pain who report relief with NSAIDs in the absence of contraindications.
For severe pain, rapidly initiate parenteral opioids. Calculate the parenteral opioid dose based on daily short-acting opioids.
Administer opioids using the subcutaneous route when intravenous access is diffi cult.
Reassess and readminister opioids for continued severe pain every 15-30 min until pain is under control per patient report.
Initiate around-the-clock opioids by patient controlled analgesia or frequently scheduled doses vs. "prn."
Do not use meperidine unless it is the only effective opioid for an individual patient.
For patients who require antihistamine for itching caused by opioid administration, prescribe orally. Readminister ever 4-6 hr if needed.
Encourage the use of the incentive spirometer to prevent acute chest syndrome in hospitalized adults and children.
In euvolemic patients who are unable to drink fl uids, administer intravenous hydration at no more than the maintenance rate to avoid overhydration.
Use an objective sedation scale to monitor for excessive sedation.
Gradually titrate down parenteral opioids as VOE resolves.
Do not administer blood for the treatment of VOE.
Administer oxygen for patients with an oxygen saturation < 95% on room air.
Encourage use of nonpharmacological approaches to manage pain including heat and distraction.
Note . NSAID = nonsteroidal anti-infl ammatory drug; prn = as needed; SCD = sickle cell disease; VOE = vaso-occlusive episode. 
Chronic Pain and the Perception of Addiction
Many patients with SCD suffer from chronic pain and require long-term opioids ( Smith et al., 2015 ) . Patients who suffer from chronic SCD pain present atypically and may not appear distressed when performing activities of daily living ( Brown, Weisberg, Balf-Soran, & Sledge, 2015 ) . Unfortunately, this contributes to a distrust in the patient's self-report of pain when health care professionals are confronted with a patient with SCD with VOEs . Distrust of patients' reports about their painful VOEs can lead to inadequate or poorly controlled pain. Health care professionals may doubt reports of pain by patients in crisis and take this condition less seriously due to the attitudes and beliefs about addiction and concerns regarding drug-seeking behavior ( Shavers, Bakos, & Sheppard, 2010 ) . The perception that patients with SCD have higher rates of opioid addiction is not uncommon among HCPs ( Freiermuth et al., 2014 ) . There is no evidence to support the belief that patients with SCD are addicted to opiates; yet, HCPs continually label patients with SCD as addicted. These negative attitudes demonstrated by health care professionals interfere with proper pain management in SCD ( Haywood et al., 2009 ) . Acute pain during VOEs is the hallmark symptom of SCD and also the most common reason for hospital admission ( NHLBI, 2014 ) . Most patients try to treat the pain at home, but when the pain exceeds during home management, patients seek further medical care but generally only after exhausting all pharmacological options ( Adegbola et al., 2012 ; Aisiku et al., 2009 ; Booker, Blethyn, Wright, & Greenfi eld, 2006 ) . Vaso-occlusive episodes require high doses of opioids, which often lead to the perception of addiction by HCPs. Pain is a subjective fi nding, making it diffi cult to objectively measure; thus, the patient's selfreport of pain may not be considered. Research demonstrates that patients with SCD in severe pain wait signifi cantly longer to be evaluated by an HCP and experience delays in receiving much needed pain medications Tanabe et al., 2007 ) . Case managers can advocate for the patient and educate the health care team on misperceptions of addiction, the patient's usual levels of pain, and the complexity of caring for patients with SCD, which may lead to improved patient care. Case managers have an important opportunity to take the lead in identifying the factors that impede quality and safe care.
Frequent Visits
Another important barrier to care for persons with SCD is being a frequent health care visitor. Patients with SCD have more frequent hospitalizations than other patients with chronic medical conditions ( Jiang et al., 2014 ) . Patients with asthma, pneumonia, heart failure, and diabetes mellitus have lower 30-day rehospitalization rates than patients with SCD, and one in three patients with SCD are readmitted within 30 days (Brousseau, Owens, Mosso, Panepinto, & Steiner, 2010) . There are a small number of patients with SCD who have a signifi cantly high hospitalization rate, four or more hospitalizations per year, and also have longer length of stays with higher readmission rates than other Medicaid users ( Jiang et al., 2014 ) . Although this number is small, because they have a large number of visits, there is a generalization that all patients with SCD are frequent health care visitors and addicted to opioids ( Freiermuth et al., 2014 ) .
Poor provider attitudes are associated with patients with SCD who have frequent hospital visits ( Ratanawongsa et al., 2009 ) . Those same poor provider attitudes can lead to patients who delay seeking treatment, which may negatively impact their health care experience and outcomes ( Jenerette, Pierre-Louis, Matthie, & Girardeau, 2015 ) . Hospital admission and readmission rates are more complex for individuals with SCD because they require care coordination, complex medication regimens, transportation to and from day treatment centers, extensive social support, and judicious follow-up care ( Cakir et al., 2017 ) . The case manager can identify individual socioeconomic risk factors to hospitalization and rehospitalization, ensure access to adequate pain medications, and schedule follow-up provider appointments, which can reduce overall costs and prevent future hospitalizations and readmissions for patients with SCD ( Cakir et al., 2017 ) .
The case manager can take an active role in team rounds by advocating for patients with SCD by reminding staff that patient vulnerability is increased with frequent admissions and call attention to negative attitudes and delayed pain medications. Case managers can also collaborate with all team members to coordinate effective discharge plans that include individualized pain management plan of care and access to outpatient services to prevent recurring hospitalizations for SCD complications.
SCD Stigma
Persons with SCD are subjected to stigma associated with their disease and are perceived as drug seeking, inevitably infl uencing their ability to receive quality care. The need for high doses of opioids and patient requests for specifi c pain medication dosages support the false beliefs that patients are drug seeking or addicted to pain medications. Nurses report increased levels of opioid addiction and greater frustration caring for patients with SCD than physicians ( Freiermuth et al., 2014 ) . Receiving pain medication within 60 min of arrival to the ED and use of individualized dosing protocols are recommended by the NHLBI guidelines ( NHLBI, 2014 ) . Lack of adherence to these guidelines is closely associated with negative provider attitudes ( Glassberg et al., 2013 ) . Health care providers who are skeptical that patients are actually in acute pain or believe that they are addicted to pain medications may delay administration of opioids or hesitate to administer opioids ( Freiermuth et al., 2014 ; Haywood et al., 2009 ) . This stigmatization causes patients with SCD to experience longer wait times to see a physician upon arrival to an ED than do other patients with chronic conditions regardless of having presented with a higher degree of pain and a higher priority assignment in triage ( Haywood, Tanabe, Naik, Beach, & Lanzkron, 2013 ) . Patients with SCD are well aware of this misperception and often feel mistrusted and stigmatized as a result ( Booker et al., 2006 ) . This further exacerbates the stigma and increases the barrier to receiving evidence-based care. Decreasing the stigma associated with SCD and advocating for patients are integral to the case manager's role. Case managers can work with HCPs by providing education about the disease and associated complex medical and social behavioral health needs, as well as the high risk of death.
Implicit Bias
Both discrimination and unconscious bias persist in our health care system ( FitzGerald & Hurst, 2017 ; James, 2017 ) . Health care providers have implicit and explicit racial bias demonstrating positive attitudes toward White persons and negative attitudes toward persons of color ( Hall et al., 2015 ) . These biases may impact the daily management and life span of patients with SCD. The need for opioids as a primary treatment of SCD makes patients with SCD uniquely subject to racial bias as a patient population. Race negatively affects the delivery of equitable evidencebased care for patients with SCD, with negative provider attitudes contributing to the disparity ( Nelson & Hackman, 2013 ) . Case managers can advocate for racial equity, educate peers, and discuss the role of implicit racial unconscious bias in health care. The case manager can address disparities that help alleviate implicit bias as a barrier to satisfactory care for patients with SCD.
CONCLUSION
Case managers are in the unique position to minimize barriers to care and foster improved health care outcomes for patients with SCD. Assessment and recognition of the barriers to care, collaboration and care coordination, evaluation, and advocacy for comprehensive health care equity for patients with SCD are essential to the role of a case manager. Ensuring evidence-based care and facilitating delivery of equitable care may reduce hospital readmissions and decrease health care utilization, thus improving health care outcomes for patients with SCD.
